Literature DB >> 20585145

Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat.

Peter Clements1, Sally Brady, Malcolm York, Brian Berridge, Igor Mikaelian, Rosemary Nicklaus, Mitul Gandhi, Ian Roman, Clare Stamp, Dai Davies, Paul McGill, Thomas Williams, Syril Pettit, Dana Walker, John Turton.   

Abstract

We investigated the kinetics of circulating biomarker elevation, specifically correlated with morphology in acute myocardial injury. Male Hanover Wistar rats underwent biomarker and morphologic cardiac evaluation at 0.5 to seventy-two hours after a single subcutaneous isoproterenol administration (100 or 4000 microg/kg). Dose-dependent elevations of serum cardiac troponins I and T (cTnI, cTnT), and heart fatty acid-binding protein (H-FABP) occurred from 0.5 hour, peaked at two to three hours, and declined to baseline by twelve hours (H-FABP) or forty-eight to seventy-two hours (Serum cTns). They were more sensitive in detecting cardiomyocyte damage than other serum biomarkers. The Access 2 platform, an automated chemiluminescence analyzer (Beckman Coulter), showed the greatest cTnI fold-changes and low range sensitivity. Myocardial injury was detected morphologically from 0.5 hour, correlating well with loss of cTnI immunoreactivity and serum biomarker elevation at early time points. Ultrastructurally, there was no evidence of cardiomyocyte death at 0.5 hour. After three hours, a clear temporal disconnect occurred: lesion scores increased with declining cTnI, cTnT, and H-FABP values. Serum cTns are sensitive and specific markers for detecting acute/active cardiomyocyte injury in this rat model. Heart fatty acid-binding protein is a good early marker but is less sensitive and nonspecific. Release of these biomarkers begins early in myocardial injury, prior to necrosis. Assessment of cTn merits increased consideration for routine screening of acute/ongoing cardiomyocyte injury in rat toxicity studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585145     DOI: 10.1177/0192623310374969

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  13 in total

1.  Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.

Authors:  Kyuri Kim; Naseem Chini; David G Fairchild; Steven K Engle; William J Reagan; Sandra D Summers; Jon C Mirsalis
Journal:  Toxicol Pathol       Date:  2016-09-28       Impact factor: 1.902

2.  Proceedings of the 2012 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Brian R Berridge; Michael C Boyle; Michelle C Cora; Mark J Hoenerhoff; Linda Kooistra; Victoria A Laast; James P Morrison; Deepa Rao; Matthias Rinke; Katsuhiko Yoshizawa
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

3.  Heart-type fatty acid-binding protein and its relation with morphological changes in rat myocardial damage model induced by isoproterenol.

Authors:  Sabaheta Hasić; Radivoj Jadrić; Esad Cosović; Emina Kiseljaković; Zakira Mornjaković; Mira Winterhalter-Jadrić
Journal:  Bosn J Basic Med Sci       Date:  2011-11       Impact factor: 3.363

Review 4.  Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Authors:  Brian R Berridge; Vasanthi Mowat; Hirofumi Nagai; Abraham Nyska; Yoshimasa Okazaki; Peter J Clements; Matthias Rinke; Paul W Snyder; Michael C Boyle; Monique Y Wells
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

5.  Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity.

Authors:  Michal Ríha; Marie Vopršalová; Veronika Pilařová; Vladimír Semecký; Magdalena Holečková; Jaroslava Vávrová; Vladimir Palicka; Tomáš Filipský; Radomír Hrdina; Lucie Nováková; Přemysl Mladěnka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-05       Impact factor: 3.000

6.  Impact of the inspiratory oxygen fraction on the cardiac output during jugulo-femoral venoarterial extracorporeal membrane oxygenation in the rat.

Authors:  Fabian Edinger; Emmanuel Schneck; Charlotte Schulte; Goetz Schmidt; Johannes Gehron; Michael Sander; Christian Koch
Journal:  BMC Cardiovasc Disord       Date:  2022-04-15       Impact factor: 2.174

7.  The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats.

Authors:  Eugene Herman; Alan Knapton; Jun Zhang; Joel Estis; John Todd; Steven Lipshultz
Journal:  Pharmacol Res Perspect       Date:  2014-03-03

8.  Differential analysis of transient increases of serum cTnI in response to handling in rats.

Authors:  Igor Mikaelian; Michael E Dunn; Diane R Mould; Gerard Hirkaler; Wanping Geng; Denise Coluccio; Rosemary Nicklaus; Thomas Singer; Micaela Reddy
Journal:  Pharmacol Res Perspect       Date:  2013-12-05

9.  Prognostic Value of Troponin I for Infarct Size to Improve Preclinical Myocardial Infarction Small Animal Models.

Authors:  Aurélien Frobert; Jérémy Valentin; Jean-Luc Magnin; Erwin Riedo; Stéphane Cook; Marie-Noëlle Giraud
Journal:  Front Physiol       Date:  2015-11-27       Impact factor: 4.566

10.  Cardioprotection of cortistatin against isoproterenol-induced myocardial injury in rats.

Authors:  Wenjia Chen; Juan Liang; Yu Fu; Yuanyuan Jin; Runan Yan; Jinyu Chi; Wenxiu Liu; Yue Liu; Xinhua Yin
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.